Please ensure Javascript is enabled for purposes of website accessibility Contrarian Fund - Janus Henderson Investors - US Investor
For Individual Investors in the US

Contrarian Fund Holdings

Full Portfolio Holdings

(As of January 31, 2025)

% OF INVESTMENTS
Surgery Partners Inc 5.54
Oracle Corp 5.44
Capital One Financial Corp 5.26
Caesars Entertainment Inc 4.87
Intercontinental Exchange Inc 4.51
PNC Financial Services Group Inc 4.39
UnitedHealth Group Inc 4.12
Chart Industries Inc 3.96
Western Alliance Bancorp 3.90
Amazon.com Inc 3.87
Marvell Technology Inc 3.82
Taiwan Semiconductor Manufacturing Co Ltd (ADR) 3.25
Dell Technologies Inc 2.75
Globus Medical Inc 2.59
Howmet Aerospace Inc 2.49
Argenx SE (ADR) 2.45
3M Co 2.36
Madrigal Pharmaceuticals Inc 2.36
Vertiv Holdings Co 2.19
Monster Beverage Corp 2.04
Flutter Entertainment PLC 2.01
Sempra 1.98
Core & Main Inc 1.73
Freeport-McMoRan Inc 1.62
Hong Kong Exchanges & Clearing Ltd 1.58
Galderma Group AG 1.52
Lantheus Holdings Inc 1.48
Cullen/Frost Bankers Inc 1.46
Sotera Health Co 1.27
Sportradar Group AG 1.24
Teleflex Inc 1.13
Vaxcyte Inc 1.09
HubSpot Inc 1.07
Builders FirstSource Inc 1.04
Beauty Health Co, 1.25%, 10/01/26 0.83
Constellium SE 0.82
Ferguson Enterprises Inc/DE 0.80
Crown Holdings Inc 0.75
Beauty Health Co 0.31
AST SpaceMobile Inc 0.30
ASTS US 21Feb25 Call (AMERICAN PHYSICAL) BAML OTC 50 0.00
CZR US 21Feb25 Put (AMERICAN PHYSICAL) GS OTC 30 0.00
VRT US 21Mar25 Call (AMERICAN PHYSICAL) GS OTC 190 0.00
VRT US 21Feb25 Call (AMERICAN PHYSICAL) JPM OTC 160 0.00
Cash & Equivalents 3.81
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.